Search result for 'gmp'

Glenmark Pharmaceuticals reported a consolidated profit after tax of Rs 348 crore in Q3 FY25, driven by strong regional performance. The company also announced a USFDA inspection at its Indore...

Venus Remedies secures renewed EU GMP certification for its manufacturing facility, enabling expansion in European and global markets for antibiotics and oncology treatments.

India's Health Ministry grants MSME pharma companies an additional year to meet revised GMP standards under Schedule M, pushing the deadline to December 31, 2025. The decision comes after requests...

Aurobindo Pharma, Glenmark, and Zydus are recalling products in the US due to manufacturing issues, including impurities above FDA limits. Learn more about the recalls and affected products.

Dr Reddy's Laboratories received seven observations from the USFDA following an inspection of its Bollaram facility. The company will address the observations within the stipulated timeline.

Aurobindo Pharma's Hyderabad-based biosimilars facility receives GMP certification from the European Medicines Agency, paving the way for approvals for three biosimilars.

Venus Remedies receives GMP approval from Malaysia's NPRA for its robotic pre-filled syringe facility, marking a significant milestone for the company's commitment to quality and technological...

Torrent Pharmaceuticals received a Form 483 with one observation from the USFDA after an inspection of its Pithampur manufacturing facility. The observation is procedural in nature and the company...

Ingka Centres, part of the Ingka Group, will invest Rs 5,500 crore in its second meeting place in Noida, India, under the Lykli brand. This will be the company's first meeting place with a hotel.

Goodveda, a D2C Ayurveda brand, plans to raise USD 1 million to fuel its expansion plans. The company is experiencing significant growth driven by rising demand for healthy and convenient Ayurvedic...

Biocon's Q1 profit jumps six-fold to Rs 660 crore, driven by a one-time gain from the Biocon Biologics and Eris Lifesciences collaboration. Revenue also grew slightly.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

Biocon Biologics receives approval from the EMA to manufacture biosimilar Bevacizumab at its Bengaluru facility, expanding capacity for European markets. The company also received GMP certificates...

Biocon received four observations from the USFDA after an inspection of its API facility in Visakhapatnam, Andhra Pradesh. The company will address the observations within the stipulated time.

Torrent Pharmaceuticals received a Form 483 with five observations from the USFDA after an inspection of its Gujarat manufacturing plant. The company will respond to the observations within the...

India's pharma industry expects sustained growth in 2024, focusing on quality, innovation, and collaboration to meet evolving healthcare needs.

Gujarat boasts over 4,000 pharma manufacturing units, contributing significantly to India's pharma production and exports. Learn more about its dominance in the sector.